retatrutide clinical trials retatrutide dosing dose dosage a 9-week trip on — LessWrong retatrutide clinical trial dosing frequency – People Are Injecting Themselves With

Understanding how peptides transform your body at the cellular level sets the stage for exploring the specific protocols and medical oversight that make these results possible and safe

This makes it a notably selective secretagogue and a strong agonist for the growth hormone/ghrelin secretagogue receptor

2025 Sep 2;5(5):oeaf117

The structural consequence of this attrition is well-understood but worth stating plainly: it compresses the window during which a company must recoup sunk R&D costs that, according to the Tufts Center for the Study of Drug Development, now average over $2.6 billion per approved drug when accounting for the cost of failures

They are not FDA approved and have not been evaluated for safety and effectiveness by the FDA